Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

NCT01635959 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3170

Last updated 2014-10-03

No results posted yet for this study

Summary

The purpose of this study is to calculate the prevalence of gastroesophageal reflux disease (GERD) by mean of GERD-Q questionnaire in patients with upper gastrointestinal tract symptoms in Egypt.

Conditions

  • Patients With Upper Gastro-intestinal Symptoms

Sponsors & Collaborators

Principal Investigators

  • Dina A Ahmed, MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01635959 on ClinicalTrials.gov